Terminated NA INTERVENTIONAL 2-arm NCT02002234

Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI) (HeMMI)

Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial

Sponsor: University of the Philippines

Conditions Infarction

Interventions Hemicraniotomy Standard medical treatment

Updated 6 times since 2017 Last updated: Apr 16, 2020 Started: Jan 31, 2002 Primary completion: Dec 31, 2009 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment for the study was terminated due to slow recruitment

Other terminated trials from University of the Philippines

Covid19 · Phase PHASE2/PHASE3 · Jun 2021

See all terminations from University of the Philippines

A NA clinical study on Infarction, this trial is terminated or withdrawn. The trial is conducted by University of the Philippines and has accumulated 6 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
May 2020 — Jan 2021 [monthly]

Terminated NA

Phase: PHASE3 → NA
Jun 2018 — May 2020 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of the Philippines

Data source: University of the Philippines

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manila, Philippines